| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8215925 | International Journal of Radiation Oncology*Biology*Physics | 2015 | 32 Pages |
Abstract
MnBuOE widens the therapeutic margin by decreasing the dose of radiation required to control tumor, while increasing normal tissue resistance to RT-mediated injury. This is the first study to quantitatively demonstrate the magnitude of a single drug's ability to radioprotect normal tissue while radiosensitizing tumor.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Kathleen A. PhD, Mary-Keara DVM, Artak PhD, Kingshuk PhD, Andrew N. PhD, Kenneth H. BS, Gregory M. PhD, Samuel R. BS, Chelsea D. PhD, Won MD, Shiva K. PhD, Tin PhD, Huaxin MD, David S. MD, David M. MD, Ivan PhD, Ines PhD, Mark W. DVM, PhD,